These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1627 related items for PubMed ID: 19792990

  • 1. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.
    Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613
    [Abstract] [Full Text] [Related]

  • 3. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun 15; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 4. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S, Alexander JW, Schroeder TJ, First MR.
    Clin Transplant; 1996 Apr 15; 10(2):186-90. PubMed ID: 8664516
    [Abstract] [Full Text] [Related]

  • 5. Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.
    Hardinger KL, Brennan DC, Schnitzler MA.
    Transplantation; 2009 May 15; 87(9):1372-6. PubMed ID: 19424038
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 7. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 8. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L, Kamar N, Durand D, Rostaing L.
    Transplant Proc; 2005 Mar 27; 37(2):892-4. PubMed ID: 15848567
    [Abstract] [Full Text] [Related]

  • 9. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J.
    Transplantation; 2009 Jan 27; 87(2):268-73. PubMed ID: 19155983
    [Abstract] [Full Text] [Related]

  • 10. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation.
    McGillicuddy JW, Taber DJ, Pilch NA, Kohout RK, Bratton CF, Chavin KD, Baliga PK.
    Prog Transplant; 2013 Mar 27; 23(1):33-8. PubMed ID: 23448818
    [Abstract] [Full Text] [Related]

  • 11. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Mar 27; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 12. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies.
    Castro MC, Araujo LM, Nahas WC, Arap S, David-Neto E, Ianhez LE.
    Transplant Proc; 2004 May 27; 36(4):874-6. PubMed ID: 15194299
    [Abstract] [Full Text] [Related]

  • 13. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R, Novick AC, Hodge E, Goormastic M, Papajcik D, Mastroianni B, Cook D.
    Urology; 1996 Jun 27; 47(6):807-12. PubMed ID: 8677568
    [Abstract] [Full Text] [Related]

  • 14. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
    Colak T, Sevmiş S, Karakayali H, Moray G, Haberal M.
    Transplant Proc; 2008 Jun 27; 40(1):123-5. PubMed ID: 18261564
    [Abstract] [Full Text] [Related]

  • 15. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May 27; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 16. Kidney transplantation from living donors: comparison of results between related and unrelated donor transplants under new immunosuppressive protocols.
    Chkhotua AB, Klein T, Shabtai EL, Yussim A, Bar-Nathan N, Shaharabani E, Lustig S, Mor E.
    Isr Med Assoc J; 2003 Sep 27; 5(9):622-5. PubMed ID: 14509149
    [Abstract] [Full Text] [Related]

  • 17. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M, Tarantino A, Berardinelli L, Finazzi S, Montagnino G, Rossini G, Scalamogna M, Cesana B, Ponticelli C.
    G Ital Nefrol; 2002 Sep 27; 19(1):49-54. PubMed ID: 12165946
    [Abstract] [Full Text] [Related]

  • 18. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D, Chen JH, Wu WZ, Yang SL, Wu GJ, Wang H, Tan JM.
    Transplant Proc; 2007 Sep 27; 39(1):69-72. PubMed ID: 17275476
    [Abstract] [Full Text] [Related]

  • 19. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 20. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.